(TSHA) Taysha Gene Therapies - Performance -15.8% in 12m
Compare TSHA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-82.96%
#148 in Group
Rel. Strength
41.67%
#4642 in Universe
Total Return 12m
-15.81%
#49 in Group
Total Return 5y
-91.15%
#116 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -18.72%
(?) Percentile in Group
12m Total Return: TSHA (-15.8%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: TSHA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TSHA
| Total Return (including Dividends) | TSHA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 77.50% | 2.02% | 2.87% |
| 3 Months | 13.90% | -15.44% | -6.42% |
| 12 Months | -15.81% | -14.02% | 9.87% |
| 5 Years | -91.15% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | TSHA | XBI | S&P 500 |
| 1 Month | 89.7% | 57% | 89.4% |
| 3 Months | 28.9% | -82.3% | -72% |
| 12 Months | -74.8% | -53.1% | 49.3% |
| 5 Years | -76.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #3 | 74.0% | 72.6% |
| 3 Month | #4 | 34.7% | 21.7% |
| 12 Month | #49 | -2.08% | -23.4% |
| 5 Years | #109 | -87.5% | -95.2% |
FAQs
Does TSHA Taysha Gene Therapies outperforms the market?
No,
over the last 12 months TSHA made -15.81%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months TSHA made 13.90%, while XBI made -15.44%.
Over the last 3 months TSHA made 13.90%, while XBI made -15.44%.
Performance Comparison TSHA vs Indeces and Sectors
TSHA vs. Indices TSHA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -17.0% | 74.6% | 35.8% | -25.7% |
| US NASDAQ 100 | QQQ | -17.3% | 72.8% | 35.4% | -27.1% |
| US Dow Jones Industrial 30 | DIA | -17.3% | 75.9% | 36.9% | -22.2% |
| German DAX 40 | DAX | -19.1% | 58.2% | 10.2% | -40.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -17.7% | 71.2% | 36.6% | -21.4% |
| Hongkong Hang Seng | HSI | -20.5% | 61.3% | 26.3% | -27.9% |
| India NIFTY 50 | INDA | -14.6% | 75.2% | 33.9% | -18.1% |
| Brasil Bovespa | EWZ | -19.1% | 66.0% | 26.6% | -9.33% |
TSHA vs. Sectors TSHA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -17.2% | 73.8% | 29.6% | -36.1% |
| Consumer Discretionary | XLY | -17.9% | 74.0% | 38.0% | -29.9% |
| Consumer Staples | XLP | -16.6% | 75.5% | 28.9% | -23.4% |
| Energy | XLE | -18.0% | 77.4% | 41.8% | -6.05% |
| Financial | XLF | -17.6% | 71.9% | 29.9% | -37.3% |
| Health Care | XLV | -13.2% | 81.9% | 41.1% | -9.89% |
| Industrial | XLI | -18.6% | 70.1% | 34.8% | -25.8% |
| Materials | XLB | -17.0% | 72.8% | 39.9% | -9.78% |
| Real Estate | XLRE | -16.7% | 71.4% | 33.4% | -29.3% |
| Technology | XLK | -17.9% | 70.8% | 38.1% | -22.8% |
| Utilities | XLU | -18.1% | 71.9% | 28.1% | -31.7% |
| Aerospace & Defense | XAR | -17.5% | 68.2% | 26.5% | -41.0% |
| Biotech | XBI | -8.93% | 75.5% | 56.9% | -1.79% |
| Homebuilder | XHB | -16.6% | 74.4% | 49.5% | -6.06% |
| Retail | XRT | -17.2% | 73.9% | 42.1% | -11.5% |